RSS   Newsletter   Contact   Advertise with us

SciVac appoints Avi Mazaltov as general manager

Share on Twitter Share on LinkedIn
Staff Writer | Cambridge, Mass., USA | April 3, 2017
VBI VaccinesApril 3, 2017, Cambridge, Mass., USA - VBI Vaccines announced the appointment of Avi Mazaltov as the global head of manufacturing and general manager of the subsidiary SciVac manufacturing site in Rehovot, Israel.
Mr. Mazaltov comes to VBI from Omrix Biopharmaceuticals, a Johnson & Johnson company, where he served as the General Manager and Director of Operations for three different sites.

At Omrix, Mr. Mazaltov was responsible for Biosurgery operations in Israel, and was a member of the Biosurgery leadership team.

Prior to joining Omrix, he held various other high-ranking operational roles including President of the Operations and Infrastructures division at Alvarion Technologies, and Director of Global Manufacturing at Teva Pharmaceuticals.


 LATEST MOVES FROM Massachusetts 


MORE INSIDE POST